Compare ALNT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNT | SYRE |
|---|---|---|
| Founded | 1962 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 903.4M | 1.1B |
| IPO Year | N/A | 2016 |
| Metric | ALNT | SYRE |
|---|---|---|
| Price | $54.52 | $34.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $50.33 | ★ $55.50 |
| AVG Volume (30 Days) | 170.0K | ★ 652.6K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 28.52 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $533,134,000.00 | N/A |
| Revenue This Year | $4.80 | N/A |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | $48.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.25 | $10.91 |
| 52 Week High | $58.13 | $34.54 |
| Indicator | ALNT | SYRE |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 79.11 |
| Support Level | $51.90 | $28.16 |
| Resistance Level | $55.36 | $34.54 |
| Average True Range (ATR) | 2.36 | 1.89 |
| MACD | 0.20 | 0.70 |
| Stochastic Oscillator | 79.74 | 96.38 |
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.